AGAPE ATP CORPORATION Purchase Obligation
AGAPE ATP CORPORATION (ATPC) had Purchase Obligation of $4.34 million as of 2021-09-30, per its 10-Q/A filed 2022-07-05.
Discontinued › Notes › Commitment and Contingencies › Purchase Obligation, Fiscal Year Maturity
us-gaap:PurchaseObligation · last filed 2022-07-05
- 2021-09-30: Purchase Obligation $4.34M.
- 2021-06-30: Purchase Obligation $4.51M.
- 2021-03-31: Purchase Obligation $4.68M.
- 2020-12-31: Purchase Obligation $4.86M.
| Period end | Purchase Obligation |
|---|---|
| 2021-09-30 | $4.34M 10-Q/A · filed 2022-07-05 |
| 2021-06-30 | $4.51M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $4.68M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $4.86M 10-K · filed 2021-03-31 |
| 2020-09-30 | $5.03M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $5.20M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $5.38M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $5.55M 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |